|
|
| | (2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride Basic information |
| Product Name: | (2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride | | Synonyms: | (2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride;Aprepitant Impurity 12 HCl;Fosaprepitant Impurity 31;Arepitam intermediate 1 hydrochloride;Aprepitant intermediate 1;Aprepitant intermediate 1 HCl;Morpholine, 2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-, (2S,3R)-;Des-1,2,4-triazol-3-one-5-methyl (2S,3R,1'R)-Aprepitant | | CAS: | 1185503-48-3 | | MF: | C20H18F7NO2 | | MW: | 437.35 | | EINECS: | | | Product Categories: | | | Mol File: | 1185503-48-3.mol | ![(2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride Structure](CAS/20150408/GIF/1185503-48-3.gif) |
| | (2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride Chemical Properties |
| Boiling point | 387.9±42.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | pka | 6.93±0.60(Predicted) |
| | (2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride Usage And Synthesis |
| Uses | Des-1,2,4-triazol-3-one-5-methyl (2S,3R,1''R)-Aprepitant is an impurity of Aprepitant (A729800); a novel selective neurokinin-1 (NK-1) receptor antagonist. In vitro studies using human liver microsomes indicate that Aprepitant is metabolised primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2E1. Antiemetic. |
| | (2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride Preparation Products And Raw materials |
|